Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer.
Cecilia MongeChangqing XieYuta MyojinKelley CoffmanDonna Mabry HronesSophie WangJonathan M HernandezBradford J WoodElliot B LevyIsraa JuburiStephen M HewittDavid E KleinerSeth M SteinbergWilliam D FiggBernadette ReddPhilip HomanMaggie CamBenjamin RufAustin G DuffyTim F GretenPublished in: Journal for immunotherapy of cancer (2023)
NCT03206073.
Keyphrases